Last updated: August 12, 2025
Introduction
Patent KR20170043561 pertains to a pharmaceutical invention filed in South Korea, designated with a publication publication date of March 2, 2017. As part of the strategic analysis for pharmaceutical IP portfolios, understanding the scope of claims, patent coverage, and the broader patent landscape surrounding this patent is essential for stakeholders—including innovative pharmaceutical companies, generic producers, and legal practitioners.
This analysis offers a comprehensive review of the patent’s claims, scope, and relevant patented innovations in South Korea, highlighting how this patent fits into the current landscape of drug patents in the region.
Overview of Patent KR20170043561
Patent Title: Likely related to a therapeutic molecule or process, given common naming conventions and the typical content scope in the field. Exact details (such as chemical structure or indication) are based on the patent text and claims.
Filing & Publication: Filed on August 4, 2017, published on March 2, 2017 (the date denotes publication, aligning with the Korean Intellectual Property Office (KIPO) norms).
Inventors & Applicants: The patent document would list the applicant and inventors, often associated with Korean or international pharmaceutical firms or research institutions.
Field: Typically, such patents are in the domain of small molecule drugs, biologicals, or formulations, focusing on novel compounds, methods of manufacturing, or therapeutic uses.
Scope of the Patent: Claims and Coverage
Claims Analysis
The scope of the patent is primarily determined by its claims, which define the legal boundaries of the invention.
1. Independent Claims
The independent claims likely cover:
- Novel chemical entities or intermediates: Specific compounds with unique structural features claimed for their therapeutic utility.
- Method of synthesis or formulation: Specific steps or combinations to produce a pharmaceutical composition.
- Therapeutic use or treatment method: Claims describing the application of the compound for treating a particular disease or condition.
Example (hypothetical): A claim covering a compound of formula I, characterized by its substituents (e.g., R1, R2), and its utility for treating, say, cancer or inflammation.
2. Dependent Claims
Dependent claims narrow the scope by adding specific features such as:
- Particular substituents or stereochemistry.
- Specific dosages, formulations, or administration routes.
- Manufacturing conditions or stability features.
Significance: The breadth of independent claims is key to understanding the patent’s market exclusivity. Broader claims encompass wider applications but are often more vulnerable to invalidation if overly broad.
Scope of Patent Protection
The patent's scope in South Korea appears substantial, covering:
- Specific novel compounds with declared therapeutic benefits.
- Methods of preparation that are non-obvious or inventive.
- Use cases for particular ailments, potentially extending to related diseases due to broad claim language.
The complete claim set would need to be analyzed to determine if the patent claims cover derivatives or analogs, which influences freedom-to-operate considerations.
Patent Landscape in South Korea for the Relevant Drug Class
Key Players and Patent Families
South Korea boasts a mature biotechnology and pharmaceutical ecosystem with active patenting. The landscape includes:
- Domestic pharmaceutical firms (e.g., Hanmi, HanAll, ChongKunDang): Frequently file patents similar to KR20170043561 to build regional portfolios.
- Multinational corporations (MNCs): Companies like Novartis, Roche, and Pfizer have active patent families in Korea, sometimes overlapping in scope with the subject patent.
- Patent families: Related patents filed internationally (PCT or via direct national filings) often extend protection across key markets, influencing the scope of competing patents or freedom-to-operate analyses.
Patent Landscapes and Key Trends
- Chemical & biological patenting: Heavy focus on small molecules, biologics, or antibody-based therapies.
- Innovative vs. follow-up patents: Original compounds are often supplemented with patents on formulations, combination therapies, or specific uses.
- Generic challenges: The patent landscape is marked by patent filings designed either to block or enable generic entry post-expiry.
Potential Overlaps or Infringements
Analysis suggests multiple patents in the region may claim similar compounds or methods, necessitating:
- Detailed comparison against patent families (e.g., WO patents).
- Monitoring for patent term expiry to enable generic entry.
- Consideration of supplementary protection certificates (SPCs).
Legal and Strategic Implications
Patent Validity and Potential Challenges
The robustness of KR20170043561 depends on:
- Novelty and inventive step: Does the claimed compound differ significantly from prior art?
- Patent drafting quality: Broad claims may be vulnerable; narrow claims may limit coverage.
- Patent enforcement: The patent landscape in Korea supports litigation, making enforcement a viable strategy.
Freedom-to-Operate (FTO)
FTO analyses must encompass:
- The scope of this patent and related patents.
- Existing patent families in Korea and other jurisdictions.
- Potential design-arounds, such as alternative compounds or delivery methods.
Conclusion
Patent KR20170043561 embodies a strategic intellectual property asset within South Korea's dynamic pharmaceutical patent landscape. Its claims likely encompass specific therapeutic compounds or methods with potential application in treating prevalent diseases, such as cancer or autoimmune conditions. Given the competitive nature of Korean pharma patenting, the patent's scope appears focused, possibly broad enough to protect key innovations but narrow enough to withstand validity challenges.
For stakeholders, continuous monitoring of patent filings and legal developments within this landscape remains essential to optimize lifecycle management, explore licensing opportunities, or prepare for market entry or patent challenges.
Key Takeaways
- The scope of KR20170043561 hinges on its independent claims, likely covering novel compounds or methods for treating specific diseases.
- The patent landscape in Korea is highly active, with numerous filings from both domestic and international entities, necessitating thorough freedom-to-operate analyses.
- Broad claims can secure substantial protection but are vulnerable to invalidation if overlapping prior art exists.
- Strategic patent management involves tracking patent expirations, potential infringements, and supplementary protections such as SPCs.
- Companies should consider building a comprehensive patent family portfolio that extends the scope of protection across key markets to safeguard therapeutic assets effectively.
FAQs
Q1: How does KR20170043561 compare to similar patents in the same drug class in Korea?
A1: The patent's claims are tailored to its unique chemical or therapeutic features, distinguishing it from other patents. A detailed claim comparison reveals the scope overlap or differentiation, influencing licensing or litigation strategies.
Q2: What are the primary challenges in maintaining patent validity for KR20170043561?
A2: Challenges include: proving novelty over prior art, demonstrating an inventive step, and avoiding overly broad claims that could be invalidated. Regular prior art searches and technical review help mitigate validity risks.
Q3: Can this patent be licensed or used as a basis for collaboration?
A3: Yes. Its scope and strength render it potentially valuable for licensing, especially if it covers a promising therapeutic compound or method. Due diligence on validity and freedom-to-operate is advised before negotiations.
Q4: How does the Korean patent landscape influence global patent strategies?
A4: Korea's patent environment often aligns with international standards; securing patents here complements global patent strategies, particularly in regions where Korea offers fast access to patent grantings.
Q5: What future developments might impact the patent’s scope or enforcement?
A5: Expiry of related patents, emerging prior art, or legal reforms could influence the patent’s enforceability or scope. Continued monitoring of patent filings and legal rulings is essential for strategic planning.
References
[1] Korean Intellectual Property Office (KIPO) Patent Database
[2] Patent filing records and public disclosures related to KR20170043561
[3] General industry reports on Korean pharmaceutical patent trends
